| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1038/NCPCARDIO0878 |
| P698 | PubMed publication ID | 17457351 |
| P50 | author | Dimitris Tousoulis | Q90167660 |
| Elli Stefanadi | Q117271853 | ||
| Christodoulos I. Stefanadis | Q17308889 | ||
| Gerasimos Siasos | Q54165911 | ||
| P2093 | author name string | Charalambos Antoniades | |
| Rainer H Böger | |||
| P2860 | cites work | Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. | Q54240963 |
| L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. | Q54310603 | ||
| Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. | Q55066644 | ||
| Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms | Q60723135 | ||
| Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits | Q60723154 | ||
| Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production | Q60723170 | ||
| Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms | Q71170633 | ||
| Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans | Q72726505 | ||
| Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis | Q73114809 | ||
| A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine | Q73325920 | ||
| Serum cholesterol level, cigarette smoking, and vasomotor responses to L-arginine in narrowed epicardial coronary arteries | Q73574912 | ||
| Oral L-arginine in patients with coronary artery disease on medical management | Q73762604 | ||
| Arginine intake and risk of coronary heart disease mortality in elderly men | Q74290899 | ||
| Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation | Q74598510 | ||
| Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling | Q74611649 | ||
| Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans | Q74645901 | ||
| Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris | Q77769400 | ||
| Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma | Q78192250 | ||
| Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant | Q24294275 | ||
| Oral L-arginine improves endothelial function in healthy individuals older than 70 years | Q28205825 | ||
| Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris | Q28246683 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine | Q33882001 | ||
| Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox | Q34961072 | ||
| L-arginine in cardiovascular disease: dream or reality? | Q35055189 | ||
| Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina | Q35584813 | ||
| Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway | Q35754540 | ||
| Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit | Q35822869 | ||
| Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor | Q35909742 | ||
| Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond | Q36438224 | ||
| Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. | Q37354435 | ||
| Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study | Q40397164 | ||
| Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke | Q41679296 | ||
| L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship | Q42126268 | ||
| Effect of local delivery of L-arginine on in-stent restenosis in humans | Q42164909 | ||
| Randomized trial of a medical food for the dietary management of chronic, stable angina | Q43477405 | ||
| Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance | Q43703668 | ||
| Oral L-arginine (and other active ingredients) for ischemic heart disease?. | Q43832644 | ||
| Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. | Q43850038 | ||
| L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients | Q44110184 | ||
| ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins | Q44264415 | ||
| Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? | Q44275915 | ||
| Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels | Q44601105 | ||
| Regulation of the expression of inducible nitric oxide synthase | Q45089049 | ||
| Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. | Q46037040 | ||
| Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit | Q46086523 | ||
| L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease | Q46685343 | ||
| L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial | Q46878007 | ||
| Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. | Q51576241 | ||
| Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine. | Q53758176 | ||
| Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. | Q54121894 | ||
| P433 | issue | 5 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 274-283 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Nature Clinical Practice Cardiovascular Medicine | Q15727036 |
| P1476 | title | Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective | |
| P478 | volume | 4 |
| Q60930929 | Analysis of repeated leukocyte DNA methylation assessments reveals persistent epigenetic alterations after an incident myocardial infarction |
| Q37370572 | Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk |
| Q43148243 | Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment |
| Q37435334 | Impaired Endothelial Nitric Oxide Synthase Homodimer Formation Triggers Development of Transplant Vasculopathy - Insights from a Murine Aortic Transplantation Model. |
| Q55353903 | LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia. |
| Q38570304 | LXRα regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. |
| Q37951442 | Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis |
| Q95642577 | NMR-based plasma metabolic profiling in patients with unstable angina |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q30916861 | Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials |
| Q42585427 | Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase |
| Q34679092 | Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase I |
| Q83131273 | Probing of L-arginine as an additive for the temperature-induced aggregation of veterinary growth hormones: fluorescence study |
| Q37662195 | The endothelial cell in health and disease: its function, dysfunction, measurement and therapy |
| Q46081694 | The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. |
| Q41808077 | The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementation |
| Q40733394 | Unveiling differences between patients with acute coronary syndrome with and without ST elevation through fingerprinting with CE-MS and HILIC-MS targeted analysis |
| Q36464510 | Variation in L-arginine intake follow demographics and lifestyle factors that may impact cardiovascular disease risk |
| Q37102697 | Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase |
Search more.